Bruxism refers to the condition of unconsciously grinding or clenching one's teeth. It is a common condition that can occur during sleep (sleep bruxism) or while awake (awake bruxism). Treating bruxism is important to prevent excessive tooth wear and damage to the jaw joint. Products used for bruxism treatment include mouth guards, anti-snoring devices, Botox injections, and pain and stress relieving medications. Mouth guards are fitted over the top or bottom row of teeth and provide a durable barrier to prevent teeth from grinding together.

The global Bruxism Treatment Market is estimated to be valued at US$ 1403.76 Bn  in 2023 and is expected to exhibit a CAGR of 11%  over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
One of the key drivers of the Bruxism Treatment Market is the increasing prevalence of stress and sleep disorders globally. Stress is one of the prominent triggers for bruxism. The fast-paced lifestyle and heavy workload have significantly increased stress levels. Growing work pressure, long working hours, and work-life imbalance contribute to heightened stress levels. Sleep disorders are also on the rise. Disorder such as insomnia, obstructive sleep apnea, and restless leg syndrome disturb sleep cycles leading to bruxism. Mouth guards are often recommended for patients with stress-related bruxism to prevent teeth damage during times of stress and frustration. Anti-snoring devices and other bruxism treatment options aid in reducing grinding associated with sleep disorders. The market is also expected to gain traction from increasing awareness regarding bruxism health effects and available treatment options.

SWOT Analysis

Strength:
- Minimally invasive bruxism treatment options like mouth guard provide effective pain relief without major side effects. This has increased adoption rate over time.
- Rising availability of specialized dentists trained in bruxism management helps address this condition more effectively through customized therapy plans.
- Growing awareness about negative health implications of uncontrolled bruxism drives more people to seek timely professional help.

Weakness:
- High costs associated with customized dental appliances and Botox therapy limits their access in low income populations.
- Lack of definite causative factors for bruxism makes it difficult to prevent recurrence in some cases despite treatment.

Opportunity:
- Tele-dentistry and online consultations can facilitate remote diagnosis and management of mild to moderate bruxism cases, especially during pandemic situation.
- Emerging neuromodulation therapies through electric stimulation promise minimally invasive options for complex bruxism cases.
- Growing geriatric population prone to stress-induced bruxism indicates rising demand for effective yet affordable treatment solutions.

Threats:
- reluctance to seek treatment due to social stigma around dental issues can delay management and exacerbate complications.
- Patent expiries of flagship bruxism drugs open doors for cheaper generics but also breed uncertainty.

Key Takeaways

The global Bruxism Treatment Market Growth is expected to witness high growth over the forecast period of 2024 to 2031 supported by rising awareness, growing geriatric population and availability of minimally invasive options. The global Bruxism Treatment Market is estimated to be valued at US$ 1403.76 Bn  in 2023 and is expected to exhibit a CAGR of 11%  over the forecast period 2024 to 2031.

The North American region currently dominates the market owing to high acceptance of aesthetic and technologically advanced dental treatments. Similarly, European nations are also early adopters with promising growth anticipated over the forecast period. The Asia Pacific region is expected to be the fastest growing market for Bruxism Treatment driven by rapidly developing healthcare infrastructure and initiatives to increase dental care access in highly populated countries like India and China. Additionally, growing medical tourism along with proliferation of dental colleges is contributing to improved availability of specialized bruxism management services in the region.

Key players related content comprises: Key players operating in the Bruxism Treatment market are Siemens, Pfizer Inc., Ipsen Biopharmaceuticals, Inc., Neurocrine Biosciences, Inc, MyoTonic, Ivoclar Vivadent AG and Henry Schein, Inc.

Explore more related article on this topic: https://www.pressreleasebulletin.com/the-global-bruxism-treatment-market-share/

Explore more related articles: https://ceocolumn.com/blog/emergence-of-unmanned-combat-aerial-vehicles-in-modern-warfare/

https://blogger-veritas.blogspot.com/2024/01/the-global-bioinformatics-market-growth.html